Groundbreaking investigations are centered on Retatrutide, a dual GIP/GLP-1 receptor which seems to offer possibly enhanced body composition benefits in relation to currently popular drugs like Mounjaro and Saxenda. This comparison requires a thorough examination at their respective biological pr